INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,665 Cr | ₹1,817 Cr | ₹1,669 Cr | ₹1,541 Cr | ₹1,242 Cr |
What is the latest Revenue of INDOCO REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,665 Cr |
| Mar2024 | ₹1,817 Cr |
| Mar2023 | ₹1,669 Cr |
| Mar2022 | ₹1,541 Cr |
| Mar2021 | ₹1,242 Cr |
How is Revenue of INDOCO REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,665 Cr | -8.38 | |
| Mar2024 | ₹1,817 Cr | 8.91 | |
| Mar2023 | ₹1,669 Cr | 8.30 | |
| Mar2022 | ₹1,541 Cr | 24.10 | |
| Mar2021 | ₹1,242 Cr | - | |
Compare Revenue of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,938.0 Cr | -1.8% | -11.2% | -35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1.8% |
-11.2% |
-35.9% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses